For many men, testosterone replacement therapy (TRT) can be life-changing—restoring energy, building muscle, improving mood, and reigniting libido. Yet, one persistent concern keeps some men from seeking help: the belief that TRT increases the risk of prostate cancer.
This idea has been around for decades, but modern research tells a very different story. Let’s separate fact from fiction and look at what the science really says about TRT and prostate health.
Where the TRT–Prostate Cancer Myth Comes From
The origins of this myth go back to research from the 1940s. Early studies observed that lowering testosterone seemed to slow the growth of prostate cancer. This led to the theory that testosterone feeds the disease.
However, these early studies had major limitations:
- They were based on small sample sizes.
- The methods for measuring testosterone and cancer progression were far less precise than they are today.
- The findings were misinterpreted to suggest that any increase in testosterone could trigger prostate cancer.
Over time, this assumption became ingrained in both the medical community and public opinion—despite a lack of strong evidence to support it.
What the Latest Research Says
Modern studies paint a different picture. Large-scale reviews and meta-analyses have found no clear evidence that TRT increases the risk of prostate cancer in men without a prior history of the disease.
In fact, some research suggests that low testosterone might actually be linked to poorerprostate health. Low testosterone can contribute to obesity, chronic inflammation, and metabolic issues—all of which can negatively impact the prostate over time.
The bottom line: In men with healthy prostates, TRT does not appear to raise the risk of developing prostate cancer.
The Role of PSA Testing and Monitoring on TRT
Safety is always a priority. Before starting TRT, your provider will typically order a PSA test (prostate-specific antigen) to establish a baseline. PSA is a protein made by the prostate, and elevated levels can indicate inflammation, enlargement, or, in rare cases, cancer.
During TRT, regular monitoring ensures:
- Early detection of any prostate changes.
- The ability to adjust therapy if PSA levels rise.
- Peace of mind that your prostate health is being watched closely.
TRT and Benign Prostatic Hyperplasia (BPH)
BPH, or an enlarged prostate, is common as men age and can cause urinary symptoms like frequent nighttime urination. Some worry that TRT might worsen BPH, but research shows the impact is generally minimal.
If BPH is present, there are effective lifestyle adjustments and medical treatments that can be combined with TRT to maintain both hormone balance and urinary comfort.
Who Should Be Cautious with TRT
TRT is not appropriate for everyone. Men with active or recent prostate cancer are typically advised to delay or avoid testosterone therapy until cleared by their oncologist.
That’s why an individualized risk assessment—including a full medical history, PSA testing, and prostate exam—is essential before beginning treatment.
The Benefits of Balanced Testosterone for Overall Men’s Health
When testosterone is too low, men often experience muscle loss, bone density decline, fatigue, depression, and weight gain. Left untreated, low testosterone can reduce quality of life and contribute to long-term health risks.
For men with symptoms and low testosterone levels, TRT—combined with careful monitoring—can restore vitality and improve overall well-being without compromising prostate health.
Conclusion
The idea that TRT causes prostate cancer is a myth rooted in outdated science. In healthy men, there is no evidence that properly monitored TRT increases prostate cancer risk. With regular screening and medical oversight, TRT can be a safe and effective way to reclaim your health.
Don’t let old fears keep you from feeling your best. Schedule a consultation with Iron Mountain Men’s Health to discuss your testosterone levels and get a comprehensive prostate health evaluation.
-1.png?w=650&h=651)